Word

FUSION BIOVENTURE FOSUN PHARMA US INNOVATION HUB

Status

Registered

Status Code

700

Status Date

Tuesday, March 28, 2023

Serial Number

97276900

Registration Number

7011438

Registration Date

Tuesday, March 28, 2023

Mark Type

3000

Filing Date

Monday, February 21, 2022

Published for Opposition

Tuesday, January 10, 2023

Trademark Owner History

Fosun Pharma USA Inc. - Original Registrant

Classifications

36 Providing venture capital, development capital, private equity and investment funding; Venture capital services, namely, providing financing to emerging and start-up companies

42 Consulting services in the field of biotechnology; Consulting services in the field of pharmaceutical research and development; Research and development in the pharmaceutical and biotechnology fields; Research and development of pharmaceuticals for the treatment of age-related diseases and cancer; Research, development, engineering and testing services in the fields of immunopharmaceuticals and vaccines; Biochemical research and development; Consulting services in the field of pharmacogenetics; Pharmaceutical research and development; Scientific research and development; Vaccine research and development

The mark consists of the blue word FUSION in capitalized text, with the orange word BIOVENTURE to its right, oriented vertically, all above the blue text FOSUN PHARMA US INNOVATION HUB, which is next to a small blue triangle. The O in FUSION is displayed around a stylized flame comprising an orange semi-circular shape at the bottom, a set of three gradient orange and yellow vertical lines in the middle, and a grid of fifteen orange dots at the top. The areas shown in white are for background only and are not claimed as part of the mark.
The color(s) blue, orange and yellow is/are claimed as a feature of the mark.
"BIOVENTURE" AND "PHARMA US INNOVATION HUB"

Trademark Events

Mar 28, 2023

Notice Of Registration Confirmation Emailed

Mar 28, 2023

Registered-Principal Register

Jan 10, 2023

Official Gazette Publication Confirmation E-Mailed

Jan 10, 2023

Published For Opposition

Dec 21, 2022

Notification Of Notice Of Publication E-Mailed

Dec 6, 2022

Approved For Pub - Principal Register

Dec 5, 2022

Assigned To Examiner

Feb 25, 2022

Notice Of Design Search Code E-Mailed

Feb 24, 2022

New Application Office Supplied Data Entered

Feb 24, 2022

New Application Entered